Referencias
- Teran M, Paolino A, Vilar J, et al. Evaluación clínica y dosimétrica de 99mTc-Hynic-IgG como agente diagnóstico de focos de infección enpacientes HIV positivos. Rev Panam Infectol 2010;12:12-7.
- Gemmel F, Dumarey N, Welling M. Future diagnostic agents. Semin Nucl Med 2009;39:11-26.
- Reyes L, Martínez E, Giglio J, Terán M. Evaluación biológica de 99mTc-Voriconazol como potencial agente de diagnóstico de infecciones fúngicas por centellografía gamma. Alasbimn Journal Year 14, N° 54, October 2011.
- Welling M, Lupetti A, Balter H, et al. 99mTc-labeledantimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 2001;42,5:788-94.
- Liu S. Bifunctional coupling agents for radiolabeling of biomolecules and target specific delivery of metallic radionuclides. Adv Drug Deliv Rev 2008;60:1347-70.
- Shaha SQ, Rafiullah Khanb M. Radiosynthesis and biological evaluation of the 99mTc-tricarbonyl moxifloxacin dithiocarbamate complex as a potential Staphylococcus aureus infection radiotracer. Appl Radiat Isot 2011;69:686–90.
- Signore A, D´Alessandria A, Lazzeri A,Dierckx R. Can we produce an image of bacteria with radiopharmaceuticals? Eur J Med Mol Imaging 2008;35:1051-5.
- Aristizabal Henao N, Vagner B. Infections of the central nervous system by Candida. J Infect Dis Immun 2011;3:79-84.
- Fortún J, Ruiz I, Martín-Dávila P, Cuenca-Estrella M. Fungal infection in solid organ recipients. Enfermedades Infecciosas y Microbiología Clínica 2012;30(S2):49–56.
- Lucignani G. The many roads to infection imaging. Eur J Nucl Med Mol Imag2007;34:1873–7.
- Lupetti A, Welling M, Mazzi U, et al. Technetium-99m labeled fluconazole and antimicrobial peptidesfor imaging of Candida albicans and Aspergillus fumigatus infections. J Nucl Biol Med 2002;29:674-9.
- Lupetti A, Welling M, Pauwels EK, Nibbering PH. Detection of fungalinfections using radiolabeled antifungalagents. Curr Drug Targets 2005;6:945-54.
- Carlo P, Brouwer WM, Welling A. Thepharmacology of radiolabeled cationic antimicrobial peptides. J Pharm Sci 2008;97:1633–51.
- Tokita N, Hasegawa S, Maruyama K, et al. Use of radiolabelled peptides for scintigraphy in non-oncologic diseases. 99mTc-Antimicrobial peptides:promising candidates for infectionimaging. Q J Nucl Med 2003;47:238-45.
- Schibili R, Schubiger PA. Current use and future potential of organometallic radiopharmaceuticals. Eur J Nucl Med 2002;29:1529-42.
- Kuijpers B, Groothuys S, Keereweer A. Synthesis of Triazole-linked glicosylamino acids and peptides. Org Lett 2004;6:3123-6.
- Alberto R, Schibili R, Egli A, Schubiger AP.A novel organometallic aqua complex oftechnetium for the labeling ofbiomolecules: Synthesis of[99mTc(OH2)3(CO)3]+from [99mTcO4]- in aqueous solution and Its reaction with a bifunctional ligand. J Am Chem Soc 1998;120:7987-8.
- Alberto R, Schibili R, Waibel R, et al. Basic aqueous chemistryof [M(OH2)3(CO)3]+ (M= Re, Tc) directed towards radiopharmaceutical application. Coordination Chemistry Reviews1999;190-192:901-19.
- Alberto R. [Tc(CO)3]+ chemistry: a promising new concept for SPET? Eur J Nucl Med Mol Imag 2003;30:1299-302.
- Schibli R, Schubiger PA. Current use and future potential of organometallic radiopharmaceuticals. Eur J Nucl Med 2002;29:1529-1542.
- Alberto R. New organometallic technetium complexes for radiopharmaceutical imaging. Top Curr Chem 2005;252:1–44.
- Agorastos N, Borsig L, Renard A, et al. Cell-specific and nuclear targeting with [M(CO)3]+ (M=99mTc, Re)-based complexes conjugated to acridine orange and bombesin. Chemistry 2007;13:3842-52.
- Gorshkov NI, Lumpov AA, Miroslavov AE, Suglobov DN. 2 + 1 Chelating Systems for Binding Organometallic Fragment Tc(CO) 3.Radiochemistry 2005;47:45-9.
- Gorshkov NI, Schibli R, Schubiger AP, et al."2 + 1" Dithiocarbamate-isocyanide chelating systems for linking M(CO) 3 + (M = 99mTc, Re) fragment to biomolecules. J Organomet Chem 2004;689:4757-63.
- Miroslavov AE, Sidorenko GV, Lumpov AA, et al. Synthesis and properties of 99Tc(I) and 99mTc(I) hexacarbonyl in aqueous solutions. Radiochemistry 2009;51:124-31.